Treatment resistant depression and axis I co-morbidity.

Area of Science:

• Psychiatry
• Clinical Psychology

Background:

• Treatment-resistant depression (TRD) poses significant clinical and economic challenges.
• The etiology of TRD remains unclear, with comorbidity suggested as a potential factor.
• Existing research offers limited insight into the specific causes of treatment resistance in depression.

Purpose of the Study:

• To investigate the hypothesis that TRD is associated with a higher frequency of comorbid Axis I psychiatric disorders.
• To compare the prevalence of Axis I comorbidities between patients with TRD and those without TRD.

Main Methods:

• TRD and non-TRD patient samples were recruited from separate antidepressant treatment studies.
• Axis I comorbidity was assessed using the Structured Clinical Interview for DSM-III-R (SCID-P).
• Patient groups were matched for baseline Hamilton Depression Rating Scale (HAM-D-17) scores and gender.

Main Results:

• No statistically significant differences in Axis I comorbidity were found between TRD and non-TRD groups, except for generalized anxiety disorder.
• Non-TRD patients exhibited higher rates of both lifetime and current generalized anxiety disorder comorbidity compared to TRD patients.
• The findings did not support the proposed link between higher Axis I comorbidity and treatment resistance in depression.

Conclusions:

• The study's results do not support the notion that TRD is characterized by increased Axis I comorbidity.
• Contrary to expectations, non-TRD patients demonstrated higher comorbidity rates for generalized anxiety disorder.
• These findings suggest that Axis I comorbidity may not be a primary driver of treatment resistance in depression.